West Pharmaceutical Services, Inc. Stock

$240.98

0.18% today

NYSE, Aug 08, 10:00 pm CET

ISIN

US9553061055

Symbol

WST

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

West Pharmaceutical Services, Inc. Stock price

$240.54

-33.01 12.07% 5Y

NYSE, Closing price Thu, Aug 07 2025

+3.26 1.37%

ISIN

US9553061055

Symbol

WST

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$17.1b

Enterprise Value

$16.8b

Net debt

positive

Cash

$509.7m

Shares outstanding

71.9m

Valuation (TTM | estimate)

P/E

35.8 | 38.0

P/S

5.8 | 5.6

EV/Sales

5.7 | 5.5

EV/FCF

48.9

P/B

5.8

Dividends

DPS

$0.82

Yield 1Y | 5Y

0.3% | 0.2%

Growth 1Y | 5Y

5.1% | 5.8%

Payout 1Y | 3Y

12.3% | 10.5%

Increased

25 Years

Financials (TTM | estimate)

Revenue

$3.0b | $3.1b

EBITDA

$778.2m | $744.6m

EBIT

$615.9m | $576.2m

Net Income

$487.7m | $455.7m

Free Cash Flow

$344.0m

Growth (TTM | estimate)

Revenue

2.9% | 5.7%

EBITDA

3.7% | 0.0%

EBIT

2.0% | -2.3%

Net Income

-7.1% | -7.5%

Free Cash Flow

-3.7%

Financial Health

Equity Ratio

73.6%

Return on Equity

18.4%

ROCE

18.4%

ROIC

16.5%

Debt/Equity

0.1

EPS

$6.7

FCF per Share

$4.8

Short interest

3.4%

Employees

11k

Rev per Employee

$270.0k

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Get Started for Free Today

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

??

19 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

14x Buy

74%

5x Hold

26%

More details on Analyst Estimates Including Price Targets

19 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy

74%

Hold

26%

Analyst Estimates with Stock Price Targets

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	2,960 2,960	3% 3% 100%
- Direct Costs	1,916 1,916	4% 4% 65%
Gross Profit	1,044 1,044	2% 2% 35%
- Selling and Administrative Expenses	350 350	0% 0% 12%
- Research and Development Expense	69 69	1% 1% 2%
EBITDA	778 778	4% 4% 26%
- Depreciation and Amortization	162 162	11% 11% 5%
EBIT (Operating Income) EBIT	616 616	2% 2% 21%
Net Profit	488 488	7% 7% 16%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

West Pharmaceutical Services, Inc. Stock News

Positive

Seeking Alpha

●

2 days ago

Top 50 High-Quality Dividend Stocks For August 2025

My investable universe of 50 high-quality dividend growth stocks aims to identify attractive opportunities based on valuation and future return potential. Currently, 20 stocks offer an estimated future return of at least 10%, with 10 of these also appearing potentially undervalued by my Free Cash Flow model. Top highlighted stocks like MKTX, RACE, RMD, MSCI, and TTC combine strong free cash flo...

Positive

Seeking Alpha

●

9 days ago

West Pharmaceutical: Q2 Earnings Suggest Recovery

West Pharmaceutical Services, Inc.'s Q2 results signal a return to growth, driven by strong demand for high-value products and GLP-1 agonist components. I am revamping my bullish thesis: GLP-1 drugs now provide a powerful, sustained growth catalyst beyond the company's traditional biologics and injectable therapeutics exposure. Risks include elevated valuation, potential competition, and the th...

Neutral

GlobeNewsWire

●

10 days ago

Kuehn Law Encourages Investors of West Pharmaceutical Services, Inc. to Contact Law Firm

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of West Pharmaceutical Services, Inc. (NYSE: WST) breached their fiduciary duties to shareholders.

More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office	United States
CEO	Eric Green
Employees	10,600
Founded	1923
Website	www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now